The Food and Drug Administration on Tuesday approved Novo Nordisk's Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

March is National Kidney Month ... MD is a paid Novo Nordisk, Inc. spokesperson. Only Novo Nordisk manufactures FDA-approved semaglutide medicines, like Ozempic®. If the label doesn’t ...

The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA's ...

The FDA's decision means Ozempic can now be used to reduce ... American adults are living with chronic kidney disease, according to Novo Nordisk. Diabetes is a key risk factor for kidney disease.